Topic
Thoracic Oncology
7 Podcasts • 6 Cases • 2 Courses on BackTable
Hear how experienced clinicians in Thoracic Oncology approach day-to-day decision-making on BackTable. Learn from podcasts, cases, and courses curated by physician content creators. Get the BackTable app to follow this Topic and hear more of the conversations that matter to your practice.
Episode # 47 • 10 Feb 2026
NSCLC Treatment: Bispecific Antibodies & EGFR Mutations
with Dr. Wade Iams, Dr. Kate Baker
Bispecific antibodies are emerging as an important therapeutic class in non-small cell lung cancer (NSCLC); but how do they work, where do they fit in clinical practice, and what should oncologists be thinking about next? In this episode of Back Table Tumor Board, Dr. Kate Baker and Dr. Wade Iams from Tennessee Oncology answer these questions and more.
More on Thoracic Oncology
Loading recent podcasts…
Tumor Board # 47
Feb 9, 2026
with Dr. Wade Iams, Dr. Kate Baker
Bispecific antibodies are emerging as an important therapeutic class in non-small cell lung cancer (NSCLC); but how do...
Tumor Board # 37
Nov 24, 2025
with Dr. Alan Lee, Dr. Scott Oh, Dr. Robert Suh, Dr. Scott Genshaft, Dr. Venkatesh Krishnasamy
Why might the standard RECIST criteria fail to accurately track success after tumor ablation, and what should you look...
Tumor Board # 35
Nov 13, 2025
with Dr. Scott Atay, Dr. Karen Reckamp, Dr. Alan Lee, Dr. Scott Oh, Dr. Scott Genshaft
When cancer spreads to the brain, what is the best approach: immediate local treatment or systemic immunotherapy first?...
Vascular & IR # 464
Jul 15, 2024
with Dr. Venkatesh Krishnasamy, Dr. Aaron Fritts
Dr. Venkatesh Krishnasamy shares techniques and specific cases for challenging lung biopsies, his insights on...
2,200+ listens
Tumor Board # 46
Feb 2, 2026
with Dr. William Moore, Dr. Daniel Sterman, Dr. Ben Cooper
Pulsed electric field (PEF) therapy is an emerging cancer treatment that utilizes short electrical pulses to disrupt...
Tumor Board # 36
Nov 17, 2025
with Dr. Karen Reckamp, Dr. Scott Atay, Dr. Scott Genshaft, Dr. Venkatesh Krishnasamy
How do leading oncologists interpret the abundance of molecular tests, genomic data, and biomarkers to create a lung...
Tumor Board # 34
Nov 10, 2025
with Dr. Scott Genshaft, Dr. Karen Reckamp, Dr. Scott Atay, Dr. Scott Oh, Dr. Alan Lee
As lung cancer treatments become more complex, is a collaborative tumor board more essential than ever? We’re kicking...
Tumor Board Case
Nov 24, 2025
with Dr. Alan Lee, Dr. Scott Oh, Dr. Robert Suh, Dr. Scott Genshaft and Dr. Venkatesh Krishnasamy
VI Case
Jul 15, 2024
with Dr. Venkatesh Krishnasamy and Dr. Aaron Fritts
VI Case
Jul 15, 2024
with Dr. Venkatesh Krishnasamy and Dr. Aaron Fritts
Tumor Board Case
Nov 24, 2025
with Dr. Alan Lee, Dr. Scott Oh, Dr. Robert Suh, Dr. Scott Genshaft and Dr. Venkatesh Krishnasamy
VI Case
Jul 15, 2024
with Dr. Venkatesh Krishnasamy and Dr. Aaron Fritts
Tumor Board Case
Nov 10, 2025
with Dr. Scott Genshaft, Dr. Karen Reckamp, Dr. Scott Atay, Dr. Scott Oh and Dr. Alan Lee
Tumor Board Course
2 CME/CE credits, 2.5 hours, 26 lessons
Tumor Board Course
2 CME/CE credits, 2.5 hours, 19 lessons
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.